Intrexon climbs on Griffin Securities initiation

Shares of Intrexon (XON +4.3%) climb after Griffin Securities initiates the synthetic biotech at Buy with a PT of $36 (potential upside of 56.5%).

Griffin joins JPMorgan and Mizuho, who carry Overweight and Buy ratings respectively on XON and a PT of $30.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs